Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Vaccine Mandates topic
No spam. Unsubscribe anytime.
Senate panel hears broad testimony for and against tightening state vaccine‑mandate standards in HB 679
Summary
Representative Kelly Potenza told the committee House Bill 679 would limit school and childcare vaccine mandates to immunizations that prevent transmission; supporters argued for parental choice and constitutional limits on mandates, while medical societies, nurses, DHHS epidemiologists and pediatricians urged the committee to oppose the change,
Get email alerts on the Vaccine Mandates topic
No spam. Unsubscribe anytime.
Representative Kelly Potenza, sponsor of House Bill 679, told the Senate Health and Human Services Committee she is proposing a narrower legal test for when the state may require vaccines for school and childcare entry: the bill would limit mandates to vaccines “that prevent transmission of disease,” and she argued vaccines that do not block transmission should be left to parental decision.
Nut graf: The hearing drew an extended, partisan and technical debate. Supporters framed HB 679 as a protection of parental choice and a clarification of constitutional limits on public‑health mandates; medical organizations, public‑health officials and many clinicians warned the change would weaken herd protections, put federal child‑care funding at risk and make New Hampshire an outlier.
Supporters’ testimony: Representative Potenza argued that some mandated vaccines (she cited polio/IPV, tetanus and pertussis in written materials) primarily protect the vaccinated individual rather than preventing transmission, and that mandates should require demonstrable community protection. Yuri Polozov, a former House committee member, and several public commentators argued the U.S. Supreme Court’s Jacobson decision supports limiting mandates to vaccines that prevent transmission. Several private citizens urged the committee to move the bill as a means to restore public trust and parental choice.
Opponents’ testimony: The New Hampshire Medical Society, the New Hampshire Nurses Association, the New Hampshire Chapter of the American Academy of Pediatrics, the New Hampshire Pharmacists Association and individual clinicians opposed HB 679. They said the bill’s language is vague and would remove public‑health flexibility. Colleen Smith, bureau chief of Infectious Disease Control at DHHS, and Dr. Ben Chan, the state epidemiologist, testified that the bill’s transmission‑only standard is not how vaccines are evaluated in clinical practice; licensing trials focus on prevention of symptomatic disease and severe outcomes, and real‑world effectiveness and transmission effects are assessed in post‑licensure surveillance. They warned that the bill could make it difficult for the department to require vaccines for childcare and school and put federal Child Care and Development Fund (CCDF) dollars at risk.
Clinicians and public health witnesses pointed to historical declines in diseases after vaccination (for example, Haemophilus influenzae type b and polio) and said even vaccines that do not confer sterilizing immunity can substantially reduce transmission and severe disease. Nurses and pediatricians warned the bill could lower vaccination uptake and increase outbreaks, citing measles and pertussis as examples. DHHS and early‑childhood advocates warned that CCDF certification language requires incorporation of current public‑health immunization recommendations and that changing the statutory standard could jeopardize approximately $40–80 million in federal child‑care funding over the biennium.
Ending: After several hours of testimony from more than 40 witnesses, the committee did not take an immediate vote. The hearing record shows deep disagreement: advocates for parental choice urged the committee to proceed; public health and clinical professions urged it to vote ITL (inexpedient to legislate).

